Name : Epsa Patel(13Y/F)

Date : 01 Dec 2024

Test Asked : Aarogyam Basic 2 With Utsh, Vitamin D Total And B12 Combo
Se
Report Status: Complete Report
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY :
MAMTA BHAWAN OPP SP OFFICE NYAN MARG
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND 272001
B12 COMBO SE

Report Availability Summary

Note: Please refer to the table below for status of your tests.

9 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

AAROGYAM BASIC 2 WITH UTSH Ready

COMPLETE URINE ANALYSIS Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

IRON DEFICIENCY PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready

VITAMIN D TOTAL AND B12 COMBO SE Ready

PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY : MAMTA BHAWAN OPP SP OFFICE NYAN MARG 272001
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
TRIG / HDL RATIO 8.38 Ratio < 3.12
COMPLETE HEMOGRAM
BASOPHILS - ABSOLUTE COUNT 0.01 X 10³ / µL 0.02 - 0.1
HEMOGLOBIN 10.4 g/dL 12.0-15.0
LYMPHOCYTE 63.1 % 20-40
MEAN CORP.HEMO.CONC(MCHC) 27.1 g/dL 31.5-34.5
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 21.8 pq 27.0-32.0
MEAN CORPUSCULAR VOLUME(MCV) 80.5 fL 83.0-101.0
MEAN PLATELET VOLUME(MPV) 11.9 fL 7.5-8.3
MONOCYTES - ABSOLUTE COUNT 0.12 X 10³ / µL 0.2 - 1.0
NEUTROPHILS 30 % 40-80
NEUTROPHILS - ABSOLUTE COUNT 1.34 X 10³ / µL 2.0-7.0
PLATELET DISTRIBUTION WIDTH(PDW) 18 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 43 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH (RDW-CV) 18.5 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 54.1 fL 39-46
COMPLETE URINE ANALYSIS
NITRITE PRESENT - Absent
URINARY PROTEIN Trace (15-30 mg/dl) mg/dL Absent
URINE BLOOD PRESENT - Absent
DIABETES
AVERAGE BLOOD GLUCOSE (ABG) 123 mg/dL 90-120
HbA1c 5.9 % < 5.7
IRON DEFICIENCY
% TRANSFERRIN SATURATION 5.15 % 13 - 45
IRON 23.92 µg/dL 50 - 170
UNSAT.IRON-BINDING CAPACITY(UIBC) 440.71 µg/dL 162 - 368
LIPID
HDL / LDL RATIO 0.24 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 22 mg/dL 40-60
LDL / HDL RATIO 4.2 Ratio 1.5-3.5
TC/ HDL CHOLESTEROL RATIO 6.6 Ratio 3-5
TRIGLYCERIDES 180 mg/dL < 150

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY : MAMTA BHAWAN OPP SP OFFICE NYAN MARG 272001
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
LIVER
ASPARTATE AMINOTRANSFERASE (SGOT ) 33.91 U/L < 31
RENAL
URIC ACID 3.06 mg/dL 3.2 - 6.1
VITAMINS
25-OH VITAMIN D (TOTAL) 6.95 ng/mL 30-100

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY MAMTA BHAWAN OPP SP OFFICE NYAN MARG
:
272001
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 6.95 ng/mL

Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building
bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.

Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

VITAMIN B-12 E.C.L.I.A 219 pg/mL
Bio. Ref. Interval. :
Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It
is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find
out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be
assessed in conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431

Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Please correlate with clinical conditions.

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:13

Report Released on (RRT) : 02 Dec 2024 06:44
Sample Type : SERUM
Labcode : 0112103848/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)
Barcode : CV634090
Page : 1 of 10
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY MAMTA BHAWAN OPP SP OFFICE NYAN MARG
:
272001
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 23.92 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170

Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 464.63 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 5.15 %
Bio. Ref. Interval. :
13 - 45

Method : Derived from IRON and TIBC values

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 440.71 µg/dL
Bio. Ref. Interval. :
162 - 368

Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:13

Report Released on (RRT) : 02 Dec 2024 06:44
Sample Type : SERUM
Labcode : 0112103848/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)
Barcode : CV634090
Page : 2 of 10
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY MAMTA BHAWAN OPP SP OFFICE NYAN MARG 272001
:
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 142 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 22 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 91 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 180 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 6.6 Ratio 3-5
TRIG / HDL RATIO CALCULATED 8.38 Ratio < 3.12
LDL / HDL RATIO CALCULATED 4.2 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.24 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 120.38 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 36.02 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:13
Report Released on (RRT) : 02 Dec 2024 06:44
Sample Type : SERUM
Labcode : 0112103848/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)

Barcode : CV634090 Page : 3 of 10

PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY MAMTA BHAWAN OPP SP OFFICE NYAN MARG 272001
:
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 156.07 U/L 92-336
BILIRUBIN - TOTAL PHOTOMETRY 0.31 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.07 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.24 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 12.93 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.91 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 19.7 U/L < 34
SGOT / SGPT RATIO CALCULATED 1.72 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.26 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.12 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.14 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.31 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:13
Report Released on (RRT) : 02 Dec 2024 06:44
Sample Type : SERUM
Labcode : 0112103848/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)

Barcode : CV634090 Page : 4 of 10

PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY MAMTA BHAWAN OPP SP OFFICE NYAN MARG 272001
:
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.18 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.59 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 15.56 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 19.65 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 33.3 Ratio < 52
CALCIUM PHOTOMETRY 9.1 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 3.06 mg/dL 3.2 - 6.1
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:13
Report Released on (RRT) : 02 Dec 2024 06:44
Sample Type : SERUM
Labcode : 0112103848/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)

Barcode : CV634090 Page : 5 of 10

 PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

MAMTA BHAWAN OPP SP OFFICE NYAN MARG 272001
REF. BY :

TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND

B12 COMBO SE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 150 ng/dL 80-210
TOTAL THYROXINE (T4) E.C.L.I.A 7.84 µg/dL 4.7-12.4
TSH - ULTRASENSITIVE E.C.L.I.A 2.82 µIU/mL 0.72-5.77

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

References :
1. Elmlinger MW, Kuhnel W, Lambretch HG, et al. Reference intervals from birth to adulthood for serum thyroxine,
T3, free T3, Free T4, TBG and TSH. Clin Chem lab med. 2001; 39:973
2. Edward CC, Carlo B. Paediatric Reference Intervals. 8th edition. 2021

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:13
Report Released on (RRT) : 02 Dec 2024 06:44
Sample Type : SERUM
Labcode : 0112103848/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)
Barcode : CV634090 Page : 6 of 10
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY MAMTA BHAWAN OPP SP OFFICE NYAN MARG
:
272001
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 5.9 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control

Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control

Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:41

Report Released on (RRT) : 02 Dec 2024 07:52
Sample Type : EDTA Whole Blood
Labcode : 0112104790/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)
Barcode : CV440696
Page : 7 of 10
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

REF. BY : MAMTA BHAWAN OPP SP OFFICE NYAN MARG
272001
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND B12
COMBO SE

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 10.4 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 38.4 % 36.0-46.0
Total RBC HF & EI 4.77 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 80.5 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 21.8 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 27.1 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 54.1 fL 39-46
Red Cell Distribution Width (RDW - CV) Calculated 18.5 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 312.2 - *Refer Note below
MENTZER INDEX Calculated 16.9 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 4.45 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 30 % 40-80
Lymphocytes Percentage Flow Cytometry 63.1 % 20-40
Monocytes Percentage Flow Cytometry 2.7 % 2-10
Eosinophils Percentage Flow Cytometry 3.8 % 1-6
Basophils Percentage Flow Cytometry 0.2 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.2 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 1.34 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.81 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.12 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.01 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.17 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.01 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 199 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 11.9 fL 7.5-8.3
Platelet Distribution Width (PDW) Calculated 18 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 43 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.24 % 0.19-0.39
Remarks : Alert!!!RBCs:Moderate anisocytosis mild poikilocytosis. Predominantly normocytic normochromic with microcytes & ovalocytes.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:41
Report Released on (RRT) : 02 Dec 2024 07:52
Sample Type : EDTA Whole Blood
Labcode : 0112104790/PP004 Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)
Barcode : CV440696 Page : 8 of 10
PROCESSED AT :
Thyrocare
CP-67, Viraj Khand,
Gomti Nagar, Lucknow – 226 010

NAME : EPSA PATEL(13Y/F) HOME COLLECTION :

MAMTA BHAWAN OPP SP OFFICE NYAN MARG
REF. BY :
272001
TEST ASKED : AAROGYAM BASIC 2 WITH UTSH,VITAMIN D TOTAL AND
B12 COMBO SE

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination 3 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change 1.025 - 1.003-1.030
PH pH indicator 6 - 5-8
Chemical Examination
URINARY PROTEIN PEI Trace (15-30 mg/dl) mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
BILE SALT Hays sulphur ABSENT - Absent
BILE PIGMENT Ehrlich reaction ABSENT - Absent
URINE BLOOD Peroxidase reaction PRESENT - Absent
NITRITE Diazo coupling PRESENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
MUCUS Microscopy ABSENT - Absent
RED BLOOD CELLS Microscopy 3 cells/HPF 0-5
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5
EPITHELIAL CELLS Microscopy 5 cells/HPF 0-5
CASTS Microscopy ABSENT - Absent
CRYSTALS Microscopy ABSENT - Absent
BACTERIA Microscopy ABSENT - Absent
YEAST Microscopy ABSENT - Absent
PARASITE Microscopy ABSENT - Absent

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

~~ End of report ~~

Sample Collected on (SCT) : 01 Dec 2024 08:21

Sample Received on (SRT) : 02 Dec 2024 02:47
Report Released on (RRT) : 02 Dec 2024 04:50
Sample Type : URINE
Dr.Shaffaly Gagneja MD (Path) Dr.Ch.Pawan.S MD(Path)
Labcode : 0112104965/PP004
Barcode : CV085412 Page : 9 of 10
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at customersupport@thyrocare.com
or call us on 022-3090 0000

+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 10 of 10